KMTS — Kestra Medical Technologies, Ltd. Common Stock

Kestra Medical Technologies, Ltd. Common Stock (KMTS) is a medical instruments & supplies company listed on NASDAQ. It is led by Brian Webster, based in 3933 Lake Washington Blvd NE, Kirkland, WA, United States, 98033. Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. This platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). It also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.

Latest reported KMTS revenue for 2025-07-31 was $19.4M. Net income was -$25.8M. Revenue was down 67.6% from 2025-04-30 to 2025-07-31. KMTS currently screens at market cap $1.24B.

Use this KMTS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the KMTS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the KMTS SEC filings page. Lician reads the product cache first so this HTML stays unique to Kestra Medical Technologies, Ltd. Common Stock even when a live quote feed is slow.